Elassaiss-Schaap, J <br/><br/>
Using Model-Based "Learn and Confirm" to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial.  [electronic resource] 

 -  CPT: pharmacometrics & systems pharmacology  01 2017 
 - 21-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2163-8306 
<br/><br/><label>Standard No.: </label>10.1002/psp4.12132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--pharmacokinetics<br/>Antineoplastic Agents--blood<br/>Clinical Trials, Phase I as Topic--statistics & numerical data<br/>Data Interpretation, Statistical<br/>Follow-Up Studies<br/>Humans<br/>Interleukin-2--antagonists & inhibitors<br/>Internationality<br/>Models, Biological<br/>Multicenter Studies as Topic--statistics & numerical data